Abstract:Objective To study the clinical effect of combined kidney transplantation and splenic fossa auxiliary heterotopic liver transplantation to treat highly sensitized recipients. Methods Combined kidney transplantation and splenic fossa auxiliary heterotopic liver transplantation from the same donor was used to treat a highly sensitized recipient with panel reactive antibodies (PRA) >50% and pre-existing donor specific antibodies (DSA). The hyperacute rejection and the function of renal after the transplant were observed. Serum samples were also collected before and after reperfusion of the liver and each time points after the transplant surgery to detect the antibody level using Luminex technology. Results The kidney function was excellent, without hyperacute rejection, after the transplant surgery and the creatinine was 141 umol/L on 6th day. But on 7th day after transplant, the creatinine was increased and the acute rejection of transplant kidney was happened. By plasmapheresis, ATG and IVIG, the acute rejection was controlled. And on 60th day after transplant, the creatinine was 131 umol/L. After reperfusion of the liver and at 3 house postoperatively, the fluorescent value of pre-existing antibodies down to below 500. On 7th day after transplant, the fluorescent value increased and slowly decreased at later time points. Antigen test using Luminex technology shows that pre-existing DSA were DR8 and DQ6. After reperfusion of the liver and at 3 house postoperatively, the fluorescent value of DR8 and DQ6 all down to below 500. DR8 rose to 17,311 on 7th day after transplant and 28th day 7,471, 60th day 12,258. DQ6 rose to 6,054 on 7th day after transplant and 28th day 625, 60th day 1,004. Conclusions Combined kidney transplantation and splenic fossa auxiliary heterotopic liver transplantation from the same donor appears to be solving ability for the problem of kidney transplantation in highly sensitized patients. Although it can protect the renal graft from risk of hyperacute rejection, the acute rejection should be prevented actively. Discussion Transplanting a renal graft in the presence of DSA or highly level PRA likely results in hyperacute rejection and graft loss. The level of antibodies after reperfusion of the liver and at 3 hour postoperatively showed the strong ability of transplanted liver absorbs the preformed antibodies. Thus, it protected the renal graft from hyperacute rejection. In the subsequent observations, the increase of pre-existing DSA and antibodies levels showed that acute rejection has happened. Through clinical intervention, the acute rejection was relieved and each observations decreased on 28th day after transplant. The levels of DSA and antibodies increased on 60th day after transplant, but the function of renal transplantation was normal. The likely reason was that liver transplantation may be played a role during the induction of peripheral tolerance. What is needed in this case is long-term clinical observation and it is not enough explained the long-term clinical effect of combined kidney transplantation and splenic fossa auxiliary heterotopic liver transplantation. But, the success in preventing the renal graft from hyperacute rejection, undoubtedly, opened the door for transplantation strategy in highly sensitized recipients.

Clinical management of kidney transplantation in highly sensitized recipients

Management experience and effect analysis of highly sensitized recipients before living kidney transplantation

Treatment of rejection and highly sensitized in kidney transplantation with double filtration plasmapheresis

Clinical Study on Renal Transplantation in Aged Recipients:A Report of 126 Cases

Preoperative Treatment and Prognosis Observation in Sensitized Recipients of Kidney Transplantation

Issues of Immunological and Hemodynamic Monitoring Before and During Kidney Transplantation in Sensitized Heart Transplant Recipient

Kidney Transplant in Highly Sensitized Patients after Desensitization with Plasmapheresis and Low-Dose Intravenous Immunoglobulin.

Clinical Analysis of 2520 Renal Transplantations in One Center

Clinical effects of double filtration plasmapheresis for sensitized recipients of cadaver kidney transplantation

A case of highly sensitized recipient after combined kidney transplantation and splenic fossa auxiliary heterotopic liver transplantation in a 28-months follow-up and review

AB96. the First Clinical Research in the World of Combined Kidney Transplantation and Splenic Fossa Auxiliary Heterotopic Liver Transplantation in Highly Sensitized Recipients

Effect of Desensitization Treatment for Highly Sensitized Uremic Patients Before Kidney Transplantation

Management of the sensitized pediatric renal transplant candidate

Immunosuppressive Therapy in Pediatric Cadaveric Renal Transplantation

Pre-transplant Impact Factors of Acute Rejection after Kidney Transplantation

Double Filtration Plasmapheresis Combined with Daclizumab in the Treatment for Sensitized Recipients of Cadaver Kidney Transplantation

[Clinical Efficacy and Safety of Combined Induction Therapy with Rituximab and ATG in Highly Sensitized Kidney Transplant Recipients].

Combined Kidney Transplantation and Splenic Fossa Auxiliary Heterotopic Liver Transplantation in a Highly Sensitized Recipient: A Case Report.

[Long-Term Survival of High-Risk Kidney Transplant Patients].

Prevalence of anti-HLA antibodies in highly sensitized kidney transplant candidates

The epitope analysis of HLA class-Ispecific antibody in highly sensitized renal transplant recipients